- Taylor, D.J., Hobby, A.E., Binns, A.M. and Crabb, D.P. (2016). How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review. BMJ Open, 6(12). doi:10.1136/bmjopen-2016-011504.
Contact details
Address
Angharad Hobby
City, University of London
Northampton Square
London EC1V 0HB
United Kingdom
Northampton Square
London EC1V 0HB
United Kingdom
About
Overview
Angharad was awarded a BSc (Hons) in Optometry from Cardiff University in 2013 and qualified as a Member of the College of Optometrists in 2014.
She joined City, University of London as part of the David Crabb Lab in the autumn of 2014 and is currently working towards her PhD. Her research looks at the functional and structural assessment of retinal disease through ocular electrophysiology and optical coherence tomography.
Angharad practices part time at Eastbourne District General Hospital where she specialises in Low Vision. She also works as a locum optometrist and is a member of the educational faculty at The Johnson and Johnson Vision Care Institute.
Angharad has been a PhD student representative for the department of Optometry at City, University of London since 2015. In January 2017 was elected to the College of Optometrists Council as a representative for the South East of England region.
Qualifications
- BSc, Cardiff University, Cardiff, United Kingdom, Oct 2010 – Jul 2013
Memberships of professional organisations
- College of Optometrists, Oct 2010 – present
- General Optical Council, Oct 2010 – present
- Association of Optometrists, Oct 2010 – present
- Member, College of Optometrists
- Member, Association of Optometrists
- Registered member, General Optical Council
Awards
- Optician Awards (2014) Leader of the Future
- AOP Awards (2014) Student of the Year
- AOP Awards (2013) Student of the Year
Teaching
Postgraduate Modules
OVM006 Glaucoma
APM024 Examination of Eyes
Research
Research Overview
Angharad's PhD is titled "An Investigation of the effect of long-term anti-VEGF therapy on retinal function and structure in people with neovascular Age-Related Macular Degeneration."
The approval of the anti-VEGF agent Ranibizumab (Lucentis) by the National Institute for Health and Care Excellence in 2008 represented a change in the management of neovascular Age-Related Macular Degeneration in the UK, for the first time offering a treatment which has the potential to improve visual function in people with this devastating condition. This project will investigate the effects on the retina of the long term suppression of a growth factor which is expressed physiologically in the healthy eye.